Maitreya Medicare
- Market cap
- ₹ 98 Cr.
- P/E
- 108.5x
- P/B
- 3.2x
- 52-week range
- 103.1 – 292.95
- ROE
- −9%
- ROCE
- −1.9%
- Dividend yield
- 0%
- Debt / equity
- 0.8
- Sector
- Healthcare Services
- Industry
- Hospital
- Listed on
- NSE SME
About
Maitreya Medicare Limited is an India-based company, which operates approximately 125 bedded, multispecialty hospitals. It provides multidisciplinary integrated healthcare services, with a focus on primary, secondary and tertiary care. It offers a comprehensive range of healthcare services and super specialties, including cardiology, urology, oncology, laparoscopic surgery, neurology, neurosurgery, spine surgery, nephrology, including dialysis, gastroenterology, gastrointestinal surgery, cardiothoracic surgery, oncosurgery, orthopedic surgery, including joint replacements and arthroscopic surgeries, gynecology and high-risk obstetrics, hepatocellular billary surgery, and critical care medicine, among others. The Company's facility consists of a Cath lab with Ivus/FFR/Rota and an approximately 20-bed Intensive Care Unit (ICU) fully equipped with ECMO/CRRT ventilators and monitors. Its subsidiaries include Maitreya Hospital Private Limited and Maitreya Lifescience Private Limited.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Hospital: 41 companies →Maitreya Medicare against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)108.5 against a typical 48.9: pricier than most peers (1st = cheapest).34th of 40
- Sales growth−2.8% against a typical +21.1% from a year earlier.30th of 34
- Profit growth−156.3% against a typical +13% from a year earlier.30th of 31
- Share price, 3 months+3.9% against a typical −10.9%.7th of 34
- Size₹ 98.3 Cr. market value against a typical ₹ 1,306.7 Cr. (1st = largest).27th of 36
Latest announcements
Exchange filings and their impact on the company.
- Board filed Sep-2026 results but figures were not readable; assume trends continue.
Maitreya Medicare's board met on October 22, 2026 and filed its unaudited financial results for the quarter and half-year ended September 30, 2026. The detailed numbers could not be extracted from the filed PDF. Pending readable figures, the business is assumed to continue near its recent run-rate of about Rs 21-24 crore per half-year with ongoing losses and elevated debt from recent expansion.
Research by Minerva Capital Research Solutions
Our research team's work on Maitreya MedicareAlso covered in
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 22 Oct 2026 | Board Meeting Intimation | MAITREYA MEDICARE LIMITED has informed the Exchange about Board Meeting to be held on 22-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . |
| 29 May 2026 | Financial Results | To consider and approve the financial results for the period ended March 31, 2026 |
| 10 Mar 2026 | Board Meeting Intimation | MAITREYA MEDICARE LIMITED has informed the Exchange about Board Meeting to be held on 10-Mar-2026 to consider ESOP. |
| 14 Nov 2025 | Board Meeting Intimation | MAITREYA MEDICARE LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2025 . |
| 30 May 2025 | Financial Results | To consider and approve the financial results for the period ended March 31, 2025 |
| 9 Dec 2024 | Other business matters | Redemption Non-Convertible CumulativeRedeemable Preference Shares |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 25 | 23 | 24 | 22 | 24 | 21 | 24 |
| Expenses | 20 | 22 | 21 | 21 | 23 | 23 | 22 |
| Operating Profit | 5 | 1 | 3 | 2 | 1 | −1 | 2 |
| OPM % | 18.4% | 5% | 13.1% | 7.6% | 4.4% | −7% | 7% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 4 | 0 | 2 | 1 | 0 | −3 | −0 |
| Tax % | 28.5% | 67.9% | 26.1% | 83.2% | 160% | −4% | 118.6% |
| Net Profit | 3 | 0 | 2 | 0 | −0 | −2 | −1 |
| EPS in Rs | 5.16 | 0.13 | 2.46 | 0.22 | −0.06 | −3.59 | −1.39 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- −6%
- 3 Years
- 2%
- TTM
- −3%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- −3,164%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
- 10 Years
- —
- 5 Years
- 10%
- 3 Years
- 3%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Maitreya Medicare | ₹ 126.00 | ₹ 98 Cr. | 108.5x | 3.2x | −9% | — |
| Apollo Hospitals Enterprise | ₹ 7,731.95 | ₹ 1,11,174 Cr. | 64.9x | 13.4x | 22% | 7.8% |
| Max Healthcare Institute | ₹ 817.00 | ₹ 79,519 Cr. | 71.5x | 9.9x | 14.3% | 17.2% |
| Fortis Healthcare | ₹ 720.00 | ₹ 54,357 Cr. | 67.9x | 7.3x | 11.1% | 11.7% |
| Aster DM Healthcare | ₹ 651.00 | ₹ 56,817 Cr. | 102.6x | 9.3x | 9.7% | 9.2% |
| Narayana Hrudayalaya | ₹ 1,667.25 | ₹ 33,862 Cr. | 48.1x | 9.1x | 19.9% | 10.3% |
Management
- Narendra Singh Tanwar
- Executive Chairman of the Board, Chief Financial Officer, Managing Director
- Kashish Surana
- Compliance Officer, Company Secretary
- Vimalkumar Natverlal Patel
- Whole Time Director
- Pranav Rohitbhai Thaker
- Whole Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.